Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FB849 |
Synonyms | |
Therapy Description |
FB849 inhibits MAP4K1 (HPK1), potentially leading to enhanced T-lymphocyte activation and antitumor activity (Cancer Res (2024) 84 (6_Supplement): 2651, Cancer Res (2024) 84 (6_Supplement): 4029). |